济南尿酸高原因济南痛风病挂什么科治疗,济南有中医治好痛风的吗,济南怎么样确定是痛风,山东痛风病能吃带鱼吗,济南痛风可以长期吃吗,山东尿酸偏高一点,北京痛风能喝绿豆汤么

BEIJING, Dec. 28 (Xinhuanet) -- A second city in East China's Fujian province will require those buying emergency contraceptive pills to show identification, Xiamen Daily reported on Wednesday.Citizens in Xiamen city of East China's Fujian province will now be asked to provide proof of identity, following a similar rule of the province's capital city of Fuzhou,According to the rule issued by Xiamen Food and Drug Administration, all pharmacies should check the buyer's ID card, register names and numbers as well as contact information, before selling pills to them.Some citizens fear the rule could invade people’s privacy. While others point out the rule may hinder efforts to protect teenagers from unplanned pregnancies.Despite the requirement, it is believed some will still be unwilling to register authentic personal information.

WASHINGTON, Dec. 20 (Xinhua) -- NASA's Kepler mission has discovered the first Earth-size planets orbiting a sun-like star outside our solar system, the U.S. space agency announce Tuesday.The planets, called Kepler-20e and Kepler-20f, are too close to their star to be in the so-called habitable zone where liquid water could exist on a planet's surface, but they are the smallest exoplanets ever confirmed around a star like our sun, according to NASA.The discovery marks the next important milestone in the ultimate search for planets like Earth. The new planets are thought to be rocky. Kepler-20e is slightly smaller than Venus, measuring 0.87 times the radius of Earth. Kepler-20f is slightly larger than Earth, measuring 1.03 times its radius. Both planets reside in a five-planet system called Kepler-20, approximately 1, 000 light-years away in the constellation Lyra.Kepler-20e orbits its parent star every 6.1 days and Kepler-20f every 19.6 days. These short orbital periods mean very hot, inhospitable worlds. Kepler-20f, at 800 degrees Fahrenheit, is similar to an average day on the planet Mercury. The surface temperature of Kepler-20e, at more than 1,400 degrees Fahrenheit, would melt glass."The primary goal of the Kepler mission is to find Earth-sized planets in the habitable zone," said Francois Fressin of the Harvard-Smithsonian Center for Astrophysics, lead author of a new study published in the journal Nature. "This discovery demonstrates for the first time that Earth-size planets exist around other stars, and that we are able to detect them."The Kepler-20 system includes three other planets that are larger than Earth but smaller than Neptune. Kepler-20b, the closest planet, Kepler-20c, the third planet, and Kepler-20d, the fifth planet, orbit their star every 3.7, 10.9 and 77.6 days. All five planets have orbits lying roughly within Mercury's orbit in our solar system. The host star belongs to the same G-type class as our sun, although it is slightly smaller and cooler.

ATHENS, Jan. 20 (Xinhua) - A seven- month- old Libyan baby died in an Athens Children's hospital on Friday in the first fatality linked to the H1N1 flu virus of the new year in Greece, local authorities reported.According to local media reports citing Greek doctors who treated the boy, he had been infected with the virus in Libya, where he was diagnosed with common flu and received insufficient therapy, before transferred to Greece.An Ukrainian woman who is being treated in another Greek hospital for pneumonia is the second severe case of the swine flu to be reported in the country this season.Last year deaths caused by the H1N1 virus in Greece climbed exceeded the 100 victims and many more patients were treated for complications caused by the virus which first emerged in 2009 in Asia and developed into a worldwide pandemic.Greek Centre for Disease Control and Prevention (KEELPNO) experts noted that Greece does not face a high risk so far this year, but suggested to people of vulnerable groups that reach up to 1.5 million persons in Greece, to get vaccinated.Last year's high number of fatalities was attributed to the fact that several people who should have been vaccinated, skimped vaccination which is not obligatory.

SAN FRANCISCO, Nov. 4 (Xinhua) -- With its popular iPhone series, Apple seized more than half of the profits generated by the top eight mobile phone manufacturers during the third quarter, said a monthly market analysis released on Friday.Apple generated a remarkable 52 percent of handset industry operating profits for the top eight OEMs (original equipment manufacturers) in the third quarter, up five percent over the same period of 2010, said Canaccord Genuity technology analyst Michael Walkley.The number was down from 57 percent in the second quarter, due to a drop in iPhone sales as customers held out for the upcoming iPhone 4S.A proud Apple customer shows off the new iPhone 4S he purchased at an Apple store in Munich, Germany.Apple's major rival in the mobile industry is Samsung. The two companies together represented 81 percent of the handset industry' s operating profits last quarter.Other major mobile phone manufacturers are Nokia, Motorola, Sony Ericsson, HTC, Research In Motion and LG.Calling it "an epic reversal of fortunes," Walkley noted that in 2007, Nokia had 67 percent of operating profits while Apple had just 4 percent. Compared with Apple's 52 percent of industry profits in the third quarter of 2011, Nokia has been relegated to its rival's former position with just 4 percent of operating profits.The analyst said he has conducted "channel checks" that show strong demand not only for the new iPhone 4S but also for the previous models of iPhone 4 and iPhone 3GS. He told technology news website AllthingsD that Apple is believed to be able to gain further value share in the December quarter and capture over 60 percent of industry profits.In a Bloomberg report on Friday, several technology analysts said the two-year-old iPhone 3GS, whose price has been slashed to zero if it is purchased with a contract, will become one of Apple' s big weapons in the coming holiday season against smartphones running Google's Android system.

WASHINGTON, Nov. 7 (Xinhua) -- U.S. researchers have demonstrated for the first time that the brain is a key player in regulating glucose (sugar) metabolism in humans.The findings, published Monday in the online edition of the Journal of Clinical Investigation, suggest that drugs targeting the brain and central nervous system could be a novel approach to treating diabetes."The brain is the body's only organ that needs a constant supply of glucose to survive, so it makes sense that it would have some say over how much glucose is produced," said study leader Meredith Hawkins, professor of medicine and director of the Global Diabetes Initiative at Yeshiva University, in a statement. "This role for the brain was demonstrated in earlier studies in rodents, but there was considerable controversy over whether the results could be applied to humans. We hope this study helps to settle the matter."In an earlier study in rodents, researchers showed that activation of potassium channels in the brain's hypothalamus sends signals to the liver that dampen its production of glucose. Those findings, published in Nature in 2005, challenged the conventional thinking that blood sugar production by the liver (the body's glucose factory) is regulated only by the pancreas (which makes insulin to metabolize glucose). But carefully performed studies on dogs, conducted at Vanderbilt University, failed to replicate the results, suggesting the Einstein findings in rodents might not be relevant to higher mammals, including humans.The current study, involving people, was aimed at resolving this controversy. Ten nondiabetic subjects were given oral diazoxide, a drug that activates potassium channels in the hypothalamus. (The drug is not used to treat diabetes.) Hormone secretion by the pancreas was controlled to ensure that any change in sugar production would only have occurred through the drug's effect on the brain. After the researchers administered the drug, blood tests revealed that patients' livers were producing significantly less glucose than before.Hawkins and her team then repeated this in rats, again giving diazoxide orally, achieving similar results. They confirmed that sufficient amounts of diazoxide crossed the blood-brain barrier to affect potassium channels in the hypothalamus. Additional experiments confirmed that diazoxide was working through the brain. Specifically, the researchers were able to completely block the effects of diazoxide by infusing a specific potassium channel blocker directly into the brain."This study confirms that the brain plays a significant role in regulating glucose production by the liver," said lead author Preeti Kishore, assistant professor of medicine. "We are now investigating whether this 'brain-to-liver' pathway is impaired in people with diabetes. If so, we may be able to restore normal glucose regulation by targeting potassium channels in the brain."